193 related articles for article (PubMed ID: 31313842)
21. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
22. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
Zhang B; Shetti D; Fan C; Wei K
Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
[TBL] [Abstract][Full Text] [Related]
23. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
24. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells.
Shuaib M; Kumar S
J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
26. TGF-β2 stimulates Tenon's capsule fibroblast proliferation in patients with glaucoma via suppression of miR-29b expression regulated by Nrf2.
Ran W; Zhu D; Feng Q
Int J Clin Exp Pathol; 2015; 8(5):4799-806. PubMed ID: 26191170
[TBL] [Abstract][Full Text] [Related]
27. miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells.
Wang Q; Li C; Zhu Z; Teng Y; Che X; Wang Y; Ma Y; Wang Y; Zheng H; Liu Y; Qu X
Anticancer Drugs; 2016 Jan; 27(1):9-16. PubMed ID: 26398931
[TBL] [Abstract][Full Text] [Related]
28. Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.
Chen YL; Zhang ZX; Shou LH; Di JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):158-165. PubMed ID: 29364483
[TBL] [Abstract][Full Text] [Related]
29. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
30. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
Liu G; Wang P; Zhang H
J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
[TBL] [Abstract][Full Text] [Related]
31. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.
Qin H; Zhu X; Liang J; Wu J; Yang Y; Wang S; Shi W; Xu J
J Dermatol Sci; 2013 Jan; 69(1):61-7. PubMed ID: 23142053
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2.
Yun Z; Yue M; Kang Z; Zhang P
Exp Cell Res; 2022 Jan; 410(1):112936. PubMed ID: 34801563
[TBL] [Abstract][Full Text] [Related]
34. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
35. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
Ying Y; Li J; Xie H; Yan H; Jin K; He L; Ma X; Wu J; Xu X; Fang J; Wang X; Zheng X; Liu B; Xie L
Cell Prolif; 2020 Feb; 53(2):e12751. PubMed ID: 31971654
[TBL] [Abstract][Full Text] [Related]
36. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract][Full Text] [Related]
37. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
38. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
[TBL] [Abstract][Full Text] [Related]
39. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
40. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
Chen H; Pan H; Qian Y; Zhou W; Liu X
Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
